SCHEMBL21758792

SCHEMBL21758792

CN1CCC(C(=O)N2CCC(c3c[nH]c4cc(F)ccc34)CC2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.60
DRD2 P14416 4/20 0.59
SLC6A4 P31645 1/20 0.59
ADRA1D P25100 3/20 0.54
APP P05067 2/20 0.53
HTR1D P28221 4/20 0.53
HTR1B P28222 4/20 0.53
HTR1A P08908 3/20 0.53
HTR1F P30939 3/20 0.53
HTR2A P28223 3/20 0.53
HTR7 P34969 3/20 0.53
KCNH2 Q12809 3/20 0.53
NAMPT P43490 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
THPO P40225 1/20 0.50
ADRA1B P35368 1/20 0.50
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18324840 0.92 HSD11B1 (0.65) HSD11B1DRD2SLC6A4ADRA1DHTR1D
SCHEMBL18324848 0.89 HSD11B1 (0.57) HSD11B1DRD2SLC6A4ADRA1DHTR1D
Bromide SCHEMBL7870891 0.86 DRD2 (0.73) DRD2SLC6A4ADRA1DAPPHTR1D
Hydrochloric Acid SCHEMBL7867314 0.86 DRD2 (0.73) DRD2SLC6A4ADRA1DAPPHTR1D
SCHEMBL16802074 0.84 KDM4E (0.69) HSD11B1DRD2SLC6A4ADRA1DHTR1D
SCHEMBL18324838 0.83 HSD11B1 (0.55) HSD11B1DRD2SLC6A4ADRA1DHTR1D
SCHEMBL6184605 0.83 DRD2 (0.61) HSD11B1DRD2SLC6A4ADRA1DHTR1D
SCHEMBL18701706 0.82 DRD2 (0.61) HSD11B1DRD2SLC6A4ADRA1DHTR1D
SCHEMBL18324841 0.81 DRD2 (0.60) HSD11B1DRD2SLC6A4ADRA1DHTR1D
SCHEMBL18324842 0.81 DRD2 (0.66) HSD11B1DRD2SLC6A4ADRA1DHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3082802-B1 TRYPTOPHAN-2,3-DIOXYGENASE (TDO) AND/OR INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS AND THEIR USE IOMET PHARMA LTD (GB) 2020-02-26 EP disclosed